An agent-based model of prostate Cancer bone metastasis progression and response to Radium223 | BMC Cancer | Full Text

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223 | BMC Cancer | Full Text

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223

Bone metastasis is the most frequent complication in prostate cancer patients and associated outcome remains fatal. Radium223 (Rad223), a bone targeting radioisotope improves overall survival in patients (3.6 ...

Authors:Stefano Casarin and Eleonora Dondossola

Citation:BMC Cancer 2020 20:605

Content type:Research article

 

Published on: 29 June 2020

• ViewFull Text
 
• ViewPDF